Analyst Price Target is $16.00
▲ +127.27% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $16.00, with a high forecast of $17.00 and a low forecast of $15.00. The average price target represents a 127.27% upside from the last price of $7.04.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.